（Key Laboratory of Veterinary Pharmaceutical Development of Ministry of Agriculture，Lanzhou Institute of Husbandry and Pharmaceutical Sciences，Chinese Academy of Agricultural Sciences，Lanzhou 730050，China）
［1］ASHRAFI K，BARGUES M D，O’NEILL S，et al.Fascioliasis：A worldwide parasitic disease of importance in travel medicine［J］. Travel Med Infect Dis，2014，12(6)：636-649.
［2］KHORAMIAN H，ARBABI M，OSQOI M M，et al.Prevalence of ruminants fascioliasis and their economic effects in Kashan，center of Iran［J］.Asian Pac J Trop Biomed，2014，4(11)：918-922.
［3］ABDEL-NASSER A，REFAAT M A.Fascioliasis prevalences among animals and human in Upper Egypt［J］.J King Saud Uni (Sci)，2010，22(1)：15-19.
［4］VIRKEL G，LIFSCHITZ A，SALLOVITZ J，et al.Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep［J］.J Vet Pharmacol Ther，2006，29(3)：213-223.
［5］MOONEY L，GOOD B，HANRAHAN J P，et al.The comparative efficacy of four anthelmintics against a natural acquired Fasciola hepatica，infection in hill sheep flock in the west of Ireland［J］.Vet Parasitol，2009，164(2-4)：201-205.
［6］COLES G C，STAFFORD K A.Activity of oxyclozanide，nitroxynil，clorsulon and albendazole against adult triclabendazole-resistant Fasciola hepatica［J］.Vet Rec，2001，148(23)：723-724.
［7］HANNA R E，MCMAHON C，ELLISON S，et al.Fasciola hepatica：A comparative survey of adult fluke resistance to triclabendazole，nitroxynil and closantel on selected upland and lowland sheep farms in Northern Ireland using faecal egg counting，coproantigen ELISA testing and fluke histology［J］. Vet Parasitol，2015，207(1-2)：34-43.
［8］崔莹.驱虫药五氯柳胺的制备［J］.现代商贸工业，2010，20：300.
CUI Y.Preparation of oxyclozanide anthelmintic［J］.Modern Business Trade Industry，2010，20：300.(in Chinese)
［9］ROY R M，SUKHLA S S.Oxyclozanide—activity against fasciola gigantica in naturally infected buffalo，cattle，sheep and goats［J］.Trop Anim Health Prod，1971，3(1)：26-31.
［10］SANABRIA R，MORENO L，ALVAREZ L，et al.Efficacy of oxyclozanide against adult Paramphistomum leydeni in naturally infected sheep［J］.Vet Parasitol，2014，206(3-4)：277-281.
［11］ARIAS M S，SANCHIS J，FRANCISCO I，et al.The efficacy of four anthelmintics against Calicophorondaubneyi in naturally infected dairy cattle［J］.Vet Parasitol，2013，197(1-2)：126-129.
［12］方晓玲.药剂学［M］.北京：人民卫生出版社，2007：107.
FANG X L.Pharmaceutics［M］.Beijing：People's Health Publishing House，2007：107.(in Chinese)
［13］国家兽药典委员会.中华人民共和国药典［M］.北京：中国农业出版社，2011：附录13.
National Veterinary Pharmacopoeia Commission.People′s Republic of China Pharmacopoeia［M］.Beijing：China Agriculture Press，2011：Appendix 13.(in Chinese)
［14］高娴，欧阳五庆，李梦云，等.托氟沙星纳米乳的制备及其急性毒性研究［J］.畜牧兽医学报，2015，46(11)：2069-2077.
GAO X，OUYANG W Q，LI M Y, et al.Study on the Preparation and Acute Toxicity of Tosufloxacin［J］.Acta Veterinaria et Zootechnica Sinica，2015，46(11)：2069-2077.(in Chinese)
［15］芮弦，欧阳五庆，吴敬超，等.纳他霉素纳米乳的制备及其质量评价［J］.中国新药杂志，2012，21(17)：2072-2076.
RUI X，OUYANG W Q，WU J C，et al.Preparation and quality evaluation of natamycin nanoemulsion［J］. Chinese Journal of New Drugs，2012，21(17)：2072-2076.(in Chinese)
［16］高新富，徐彦飞，丁召兴，等.增效磺胺嘧啶银混悬剂的制备与质量控制［J］.中国药房，2013，24(1)：60-62.
GAO X F，XU Y F，DING Z X，et al.Preparation and quality control of synergist flamazine suspension［J］.China Pharmacy，2013，24(1)：60-62.(in Chinese)
［17］SAWANT K K，PATEL M H，PATEL K.Cefdinir nanosuspension for improved oral bioavailability by media milling technique：formulation，characterization and in vitro-in vivo evaluations［J］.Drug Dev Ind Pharm，2015：1-11.
［18］陈充抒，梁艳，梁莉.纳米混悬剂的制备、表征及其应用研究进展［J］.武警医学，2013，24(4)：358-361.
CHEN C Y，LIANG Y，LIANG L.Nano suspensions，characterization and application of research progress［J］.Journal of the Chinese People’s Armed Police Forces，2013，24(4)：358-361.(in Chinese)
［19］HONG C，DANG Y，LIN G，et al.Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization：An in vitro and in vivo evaluation［J］.Int J Pharm，2014，477(1)：251-260.
［20］ROWE R C，SHESKEY P J，QUINN M E.Handbook of Pharmaceutical Excipients［M］.Sisth edition.London：Pharmaceutical Press，2009.
［21］农业部兽药评审中心.兽药研究技术指导原则汇编［M］.北京：化学工业出版社，2012：11.
Ministry of agriculture veterinary drug evaluation center.Veterinary technical research guidelines compilation［M］.Beijing：The Chemical Industry Publishers，2012：11.(in Chinese)
［22］袁开红，吴玉霞，卓海通，等.布洛芬混悬液的研制及生物利用度［J］.中国医药工业杂志，2003，34(9)：444-445.
YUAN K H，WU Y X，ZHUO H T，et al.Preparation and bioavailability of the ibuprofen suspension［J］.Chinese Journal of Pharmaceuticals，2003，34(9)：444-445.(in Chinese)
［23］金从形，李阿玲，杜有功，等.卡马西平混悬剂的研制及质量控制研究［J］.海峡药学，2010，22(5)：82-85.
JIN C X，LI A L，DU Y G，et al.Preparation and quality control study of Carbamazepine (CBZ)Suspension［J］.Strait Pharmaceutical Journal，2010，22(5)：82-85.(in Chinese)
